Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism

Maofu Fu1, Chenguang Wang, Mahadev Rao

  • 1Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC 20057, USA.

Insights

Cyclin D1 interacts with p300, repressing its activity and impacting gene expression. This finding clarifies cyclin D1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Cyclin D1 is a regulatory protein influencing cell cycle and differentiation.
  • Its precise mechanism in regulating transcription factors for differentiation is unclear.
  • Histone acetyltransferase p300 is crucial for transcription factor regulation.

Purpose of the Study:

  • To elucidate the molecular mechanism of cyclin D1 in regulating transcription factors.
  • To investigate the interaction between cyclin D1 and p300.
  • To determine how this interaction affects cellular differentiation and proliferation.

Main Methods:

  • Protein-protein interaction studies to confirm physical binding of cyclin D1 and p300.
  • Chromatin immunoprecipitation assays to identify interaction sites on promoters.
  • In vitro assays to assess histone acetyltransferase activity inhibition.
  • Microarray analysis to identify gene expression changes.

Main Results:

  • Cyclin D1 physically interacts with p300, repressing its transactivation function.
  • The interaction occurs at specific promoter regions and involves defined domains of both proteins.
  • Cyclin D1 inhibits p300's histone acetyltransferase activity.
  • Gene expression analysis revealed genes regulated by this interaction impacting cell cycle and differentiation.

Conclusions:

  • Cyclin D1 regulates p300 activity, influencing gene expression patterns.
  • This regulation plays a significant role in controlling cellular proliferation and differentiation.
  • The findings provide a novel mechanism for cyclin D1's function in cell fate determination.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.